{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:56:28Z","timestamp":1769633788075,"version":"3.49.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia \u2013 Minist\u00e9rio da Educa\u00e7\u00e3o e Ci\u00eancia","award":["PTDC\/QUI-BIQ\/112929\/2009"],"award-info":[{"award-number":["PTDC\/QUI-BIQ\/112929\/2009"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia \u2013 Minist\u00e9rio da Educa\u00e7\u00e3o e Ci\u00eancia","award":["20110007"],"award-info":[{"award-number":["20110007"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia \u2013 Minist\u00e9rio da Educa\u00e7\u00e3o e Ci\u00eancia","award":["20120006"],"award-info":[{"award-number":["20120006"]}]},{"name":"Gabinete de Apoio \u00e0 Investiga\u00e7\u00e3o Cient\u00edfica, Tecnol\u00f3gica e Inova\u00e7\u00e3o"},{"name":"Funda\u00e7\u00e3o AstraZeneca Innovative Competition 2013","award":["iMed 5.0"],"award-info":[{"award-number":["iMed 5.0"]}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["FP7-HEALTH-F3-2008-223414"],"award-info":[{"award-number":["FP7-HEALTH-F3-2008-223414"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Spanish Ministry of Economy and Competitiveness","award":["SAF2011-24899"],"award-info":[{"award-number":["SAF2011-24899"]}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2009 SGR 492"],"award-info":[{"award-number":["2009 SGR 492"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jconrel.2016.11.027","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T11:00:20Z","timestamp":1479985220000},"page":"127-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["siRNA-cell-penetrating peptides complexes as a combinatorial therapy against chronic myeloid leukemia using BV173 cell line as model"],"prefix":"10.1016","volume":"245","author":[{"given":"Jo\u00e3o Miguel","family":"Freire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas","family":"Rego de Figueiredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Salom\u00e9","family":"Veiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Andreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"Enguita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.R.B.","family":"Castanho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.11.027_bb0005","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0609.2011.01586.x","article-title":"ABL1 fusion genes in hematological malignancies: a review","volume":"86","author":"De Braekeleer","year":"2011","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0010","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0140-6736(07)61165-9","article-title":"European LeukemiaNet, chronic myeloid leukaemia","volume":"370","author":"Hehlmann","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0015","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.drudis.2013.06.001","article-title":"The background, discovery and clinical development of BCR-ABL inhibitors","volume":"18","author":"Lambert","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0020","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","article-title":"Translation of the Philadelphia chromosome into therapy for CML","volume":"112","author":"Druker","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0025","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.leukres.2013.01.021","article-title":"Occurrence and current management of side effects in chronic myeloid leukemia patients treated frontline with tyrosine kinase inhibitors","volume":"37","author":"Breccia","year":"2013","journal-title":"Leuk. Res."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0030","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1182\/blood.V98.7.2039","article-title":"Chronic myeloid leukemia: current treatment options","volume":"98","author":"Goldman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0035","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.clinthera.2010.05.003","article-title":"Treatment options for patients with chronic myeloid leukemia who are resistant to or unable to tolerate imatinib","volume":"32","author":"MHS","year":"2010","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0040","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1166\/jnn.2010.2396","article-title":"Quantum dot conjugates for targeted silencing of bcr\/abl gene by RNA interference in human myelogenous leukemia K562 cells","volume":"10","author":"Zhao","year":"2010","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0045","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jconrel.2010.04.011","article-title":"Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting bcr\u2013abl fusion gene in Chronic Myeloid Leukemia cells","volume":"145","author":"Arthanari","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0050","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jconrel.2013.05.014","article-title":"Investigating siRNA delivery to chronic myeloid leukemia K562 cells with lipophilic polymers for therapeutic BCR-ABL down-regulation","volume":"172","author":"Valencia-Serna","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0055","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/iub.1257","article-title":"Cell-penetrating peptides: a tool for effective delivery in gene-targeted therapies","volume":"66","author":"de Figueiredo","year":"2014","journal-title":"IUBMB Life."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0060","first-page":"232","article-title":"Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer","volume":"1816","author":"Bolhassani","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0065","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1021\/nn4057269","article-title":"Cell-penetrating peptides: design, synthesis, and applications","volume":"8","author":"Copolovici","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0070","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tips.2012.02.002","article-title":"Peptides for cell-selective drug delivery","volume":"33","author":"Svensen","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-matsci-062910-100359","article-title":"Advances in drug delivery","volume":"41","author":"Timko","year":"2011","journal-title":"Annu. Rev. Mater. Res."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0080","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.tips.2010.07.006","article-title":"In vivo biodistribution and efficacy of peptide mediated delivery","volume":"31","author":"Jarver","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0085","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.drudis.2012.03.002","article-title":"Cell-penetrating peptides: classes, origin, and current landscape","volume":"17","author":"Milletti","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0090","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1476-5381.2009.00057.x","article-title":"Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics","volume":"157","author":"Heitz","year":"2009","journal-title":"Brit. J. Pharmacol."},{"issue":"bas015","key":"10.1016\/j.jconrel.2016.11.027_bb0095","article-title":"CPPsite: a curated database of cell penetrating peptides","volume":"2012","author":"Gautam","year":"2012","journal-title":"Database"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0100","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1517\/17425247.2012.689285","article-title":"Cell-penetrating peptides for the delivery of nucleic acids","volume":"9","author":"Lehto","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0105","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1021\/ar200256e","article-title":"Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides","volume":"45","author":"Nakase","year":"2012","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0110","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1021\/ar3000162","article-title":"Nucleic acid delivery: the missing pieces of the puzzle?","volume":"45","author":"Nguyen","year":"2012","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0115","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1039\/c2mb25467k","article-title":"Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells","volume":"9","author":"Nakase","year":"2013","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0120","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1007\/s00018-012-0979-4","article-title":"Bioportide: an emergent concept of bioactive cell-penetrating peptides","volume":"69","author":"Howl","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0125","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/biot.201200335","article-title":"Bioportides: bioactive cell-penetrating peptides that modulate cellular dynamics","volume":"8","author":"Lukanowska","year":"2013","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081450","article-title":"Intracellular nucleic acid delivery by the supercharged dengue virus capsid protein","volume":"8","author":"Freire","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/febs.12587","article-title":"Nucleic acid delivery by cell penetrating peptides derived from dengue virus capsid protein: design and mechanism of action","volume":"281","author":"Freire","year":"2014","journal-title":"FEBS J."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0140","first-page":"23","article-title":"siRNAs encapsulated in recombinant capsid protein derived from Dengue serotype 2 virus inhibits the four serotypes of the virus and proliferation of cancer cells","volume":"193C","author":"Kumar","year":"2014","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0145","first-page":"447","article-title":"Establishment of a Ph1-positive human cell line (BV173)","volume":"70","author":"Pegoraro","year":"1983","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0150","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3324\/haematol.2009.016063","article-title":"Small interfering RNA against BCR-ABL transcripts sensitize mutated T315I cells to nilotinib","volume":"95","author":"Koldehoff","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0155","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1399-3011.1990.tb00939.x","article-title":"Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids","volume":"35","author":"Fields","year":"1990","journal-title":"Int. J. Pept. Protein Res."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0160","doi-asserted-by":"crossref","first-page":"27536","DOI":"10.1074\/jbc.M110.130955","article-title":"Escherichia coli Cell surface perturbation and disruption induced by antimicrobial peptides BP100 and pepR","volume":"285","author":"Alves","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0165","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/psc.2477","article-title":"Quantifying molecular partition of cell-penetrating peptide-cargo supramolecular complexes into lipid membranes: optimizing peptide-based drug delivery systems","volume":"19","author":"Freire","year":"2013","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0170","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/bip.22266","article-title":"Peptides as models for the structure and function of viral capsid proteins: insights on dengue virus capsid","volume":"100","author":"Freire","year":"2013","journal-title":"Biopolymers"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0175","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nprot.2010.5","article-title":"I-TASSER: a unified platform for automated protein structure and function prediction","volume":"5","author":"Roy","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0180","series-title":"The PyMOL Molecular Graphics System (DeLano Scientific LLC, Palo Alto, CA)","author":"DeLano","year":"2008"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0185","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0190","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/sj.leu.2401592","article-title":"Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease","volume":"13","author":"Van Dongen","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0195","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/cyto.990170108","article-title":"A flow cytometric method using Hoechst 33342 and propidium iodide for simultaneous cell cycle analysis and apoptosis determination in unfixed cells","volume":"17","author":"Belloc","year":"1994","journal-title":"Cytometry"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0200","first-page":"301","article-title":"Analysis of cell cycle by flow cytometry","volume":"281","author":"Pozarowski","year":"2004","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.990080101","article-title":"A pragmatic approach to the analysis of DNA histograms with a definable G1 peak","volume":"8","author":"Watson","year":"1987","journal-title":"Cytometry"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0210","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/nar\/gkj439","article-title":"Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging","volume":"34","author":"Bartlett","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0215","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jconrel.2009.07.006","article-title":"Interactions between octaarginine and U-937 human macrophages: global gene expression profiling, superoxide anion content, and cytokine production","volume":"139","author":"Kuo","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0220","doi-asserted-by":"crossref","first-page":"14863","DOI":"10.1073\/pnas.95.25.14863","article-title":"Cluster analysis and display of genome-wide expression patterns","volume":"95","author":"Eisen","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0225","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","article-title":"Origins and mechanisms of miRNAs and siRNAs","volume":"136","author":"Carthew","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0230","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ceb.2009.04.009","article-title":"Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells","volume":"21","author":"Chekulaeva","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0235","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature07228","article-title":"Widespread changes in protein synthesis induced by microRNAs","volume":"455","author":"Selbach","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0240","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tcb.2006.12.007","article-title":"Repression of protein synthesis by miRNAs: how many mechanisms?","volume":"17","author":"Pillai","year":"2007","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0245","doi-asserted-by":"crossref","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","article-title":"miRBase: annotating high confidence microRNAs using deep sequencing data","volume":"42","author":"Kozomara","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0250","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-1-62703-748-8_12","article-title":"Computational methods for microRNA target prediction","volume":"1107","author":"Hamzeiy","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0255","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2012.04.005","article-title":"Roles for MicroRNAs in conferring robustness to biological processes","volume":"149","author":"Ebert","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0260","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/nsmb.2115","article-title":"Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs","volume":"18","author":"Garcia","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0265","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrc3563","article-title":"Role of ABL family kinases in cancer: from leukaemia to solid tumours","volume":"13","author":"Greuber","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0270","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/iub.1193","article-title":"Targeting RAS\/RAF\/MEK\/ERK signaling in metastatic melanoma","volume":"65","author":"Wang","year":"2013","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0275","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jbior.2012.10.005","article-title":"IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia","volume":"53","author":"Ribeiro","year":"2013","journal-title":"Adv Biol Regul."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0280","doi-asserted-by":"crossref","first-page":"16883","DOI":"10.1073\/pnas.1108795108","article-title":"Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions","volume":"108","author":"Mishra","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0285","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","article-title":"Natural products: a continuing source of novel drug leads","volume":"1830","author":"Cragg","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0290","doi-asserted-by":"crossref","first-page":"372","DOI":"10.18632\/aging.100036","article-title":"Aging of the inceptive cellular population: the relationship between stem cells and aging","volume":"1","author":"Symonds","year":"2009","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jconrel.2016.11.027_bb0295","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.tcb.2010.05.002","article-title":"Emerging links between CDK cell cycle regulators and Wnt signaling","volume":"20","author":"Davidson","year":"2010","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0300","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.133.4.1710","article-title":"Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67","volume":"133","author":"Gerdes","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0305","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fmicb.2013.00294","article-title":"From antimicrobial to anticancer peptides. A review","volume":"4","author":"Gaspar","year":"2013","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0310","doi-asserted-by":"crossref","first-page":"D837","DOI":"10.1093\/nar\/gku892","article-title":"CancerPPD: a database of anticancer peptides and proteins","volume":"43","author":"Tyagi","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2016.11.027_bb0315","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00249-011-0682-7","article-title":"Antimicrobial peptides with cell-penetrating peptide properties and vice versa","volume":"40","author":"Splith","year":"2011","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.jconrel.2016.11.027_bb9000","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/cncr.20468","article-title":"Inhibition of bcr-abl and\/orc-abl gene expression by small interfering, double-stranded RNAs","volume":"101","author":"Ohba","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2016.11.027_bb9005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1756-8722-4-23","article-title":"Gene expression profiles in BCL11B-siRNA treated malignant T cells","volume":"4","author":"Huang","year":"2011","journal-title":"J. Hematol. Oncol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916312226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916312226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:31:59Z","timestamp":1759159919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916312226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":65,"alternative-id":["S0168365916312226"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.11.027","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"siRNA-cell-penetrating peptides complexes as a combinatorial therapy against chronic myeloid leukemia using BV173 cell line as model","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}